HomeMarkets Markets Sanofi Agrees to Pay $2.9 Billion For Provention Bio By news March 13, 2023 0 72 FacebookTwitterPinterestWhatsApp Sanofi agreed to buy Provention Bio Inc. in a $2.9 billion deal intended to bolster the French drugmaker’s portfolio of diabetes medicines with a new …This post was originally published on this site Share FacebookTwitterPinterestWhatsApp Subscribe Login Notify of new follow-up comments new replies to my comments Please login to comment 0 Comments Inline Feedbacks View all comments Stay Connected157,354FansLike396,312FollowersFollow2,290SubscribersSubscribe Latest Articles Charts Portfolio Reviews and Fed Beige Book (04/17/2024) Markets Russian Hypersonic Missiles: Unstoppable or Skeet Practice for Ukraine Markets Tesla lost over $700 billion in value since November 2021 and Elon Musk wants $45 billion for his performance as CEO Markets Beauty giant Sephora has returned to the UK after nearly 20 years – by betting on AI and gen Z Markets The Trump Jury Has a Doxing Problem Load more